Health Care · Orthopedic, Prosthetic & Surgical Appliances & Supplies · Nasdaq · CIK 798081 · FYE Jan 31 · Prices AT CLOSE 2026-07-29 (USD) — end-of-day, never a live or intraday quote
Last $10.91Day +1.68%Mkt cap $108M1Y −24.2%Off 52W high −39.4%Vol (1Y) 69.6%
Daily closing price, split-adjusted to the current basis; 3y shown of 5,278 bars on file. Sampled to 240 points — every point is a real close, none averaged. Price return, not total return (dividends excluded). Source marketstack.
| Short interest14.1% of sh out |
| Days to cover17.4d |
| 13F net flow (QoQ)+5.89% |
| Top-10 13F concentration82.3% |
| Next report (est.)2026-09-09 |
Short interest is FINRA semi-monthly, settlement 2026-07-15. 13F figures are quarterly filings, period 2026-Q1 — a lower bound on true ownership.
| Sales (TTM)$193.3M |
| Earnings (TTM)-$21.0M |
| ROE−18.4% |
| Net margin−13.1% |
| Debt / equity0.25× |
| Sales growth 3Y19.5% |
Screener basis: ratios from the latest reported fiscal year; Sales/Earnings are trailing twelve months in the reporting currency (USD). The P/E is a trailing FULL-YEAR P/E, not TTM. Missing lines are absent from the filings, never imputed.
| YTD+23.4% |
| 1Y−24.2% |
| 3Y−28.2% |
| 5Y−56.8% |
| 10Y+10.0% |
| Since incept. (ann.)−1.0% |
Total return through 2026-07-29 · series begins 2005-07-11. Only the windows this history actually covers are shown.
| Ann. volatility (1Y)69.6% |
| Ann. volatility (3Y)57.3% |
| Sharpe (1Y)−0.05 |
| Sharpe (3Y)0.12 |
| Max drawdown (1Y)−56.2% |
| Max drawdown (3Y)−71.2% |
| Beta (3Y vs SPY)1.53 |
Daily simple returns, annualized; drawdown is peak-to-trough within the window. Beta is the OLS slope of monthly returns on SPY's over three years. Each figure is labeled by the window it was measured over — they are not comparable across windows.
| Manager | Shares | Value | % sh out | QoQ |
|---|---|---|---|---|
| Private Capital Management, LLC | 1.5M | $12M | 15.28% | +25.4% |
| ROYCE & ASSOCIATES LP | 1.2M | $10M | 12.30% | +5.5% |
| Pacific Ridge Capital Partners, LLC | 928,981 | $8M | 9.41% | +20.3% |
| BlackRock, Inc. | 556,437 | $5M | 5.64% | −0.9% |
| VANGUARD CAPITAL MANAGEMENT LLC | 391,300 | $3M | 3.96% | new |
| DIMENSIONAL FUND ADVISORS LP | 329,144 | $3M | 3.34% | −23.5% |
| MORGAN STANLEY | 268,900 | $2M | 2.72% | +97.6% |
| GEODE CAPITAL MANAGEMENT, LLC | 228,075 | $2M | 2.31% | +4.9% |
Reported 13F long positions as filed for 2026-Q1 (change vs 2025-Q4). 13F covers US-listed long equity only — the sum is a LOWER BOUND on institutional ownership, never a total.
| Period end | Reported | EPS | EPS YoY | Revenue | Rev YoY |
|---|---|---|---|---|---|
| 2026-04-30 | 2026-06-09 | $0.04 | — | $47.4M | +1.4% |
| 2026-01-31 | 2026-04-16 | — | — | $45.8M | — |
| 2025-10-31 | 2025-12-09 | −$1.64 | −16500.0% | $47.6M | +4.0% |
| 2025-07-31 | 2025-09-09 | $0.08 | — | $52.5M | +36.3% |
EPS and revenue as reported in this filer's own XBRL — our extraction of the filings, not a vendor consensus feed, and never a beat/miss claim (we carry no estimates). YoY compares the same fiscal quarter a year earlier. Next report 2026-09-09 is ESTIMATED from filing cadence (median gap 92d) — not company-confirmed.
